|
Investment News
PRESS RELEASE ARCHIVES FROM SEND2PRESS® NEWSWIRE
NOTICE: THIS IS ARCHIVAL CONTENT AND LIKELY OUT OF DATE.
Original editor for Send2Press: Christopher L. Simmons
Empire Relations Group Issues Gold Star Report on Accelr8 Technology Corporation
New York, NY - April 23, 2004 /Send2Press Newswire/ -- Empire Relations Group Inc. announced
today that Accelr8 Technology Corporation has been highlighted in its new Gold Star
Report™. The Gold Star Report can be viewed at EmpireRelations.com.
Kenneth Maciora, Chief Executive Officer of Empire Relations Group Inc. commented, "Accelr8
Technology Corporation's BACcelr8r™ diagnostic platform including the surface chemistry
as well as the supporting quantitative instruments represents a very intriguing platform for
the detection of medical diagnostic markers, pathogens and bio-warfare agents."
About Empire Relations Group Inc.
Empire Relations Group Inc. is a premier investor relations firm focused on assisting public
companies in the creation and marketing of their stories to the investor and investment
banking communities. Empire Relations Group focuses on increasing shareholder value for our
clients by creating investor relations programs that raise awareness among brokers,
analysts, portfolio managers, individual investors and the media.
Organization Website:
www.empirerelations.com
Source of News:
Empire Relations Group Inc.
DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the organization mentioned and/or quoted in the story. The organization providing the news to Send2Press is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements and public companies should be thoroughly researched before considering material investment. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article.
USE OF THE ABOVE NEWS ARTICLE
News is Copr. © 2004 Neotrope/Send2Press. Reproduction of this news article in any form requires written authorization. You may freely link to this article, or republish the "news release" text version linked to above under "Journalist Tools" without restriction except websites must retain /Send2Press Newswire/ as the source. Sites which offer/sell PR services or newswire services may not reprint our content without express written permission.
|
